Marshall Wace, LLP Bio Techne Corp Transaction History

Marshall Wace, LLP

$90.8 Billion
Q3 2025

A detailed history of Marshall Wace, LLP transactions in Bio Techne Corp stock. As of the latest transaction made, Marshall Wace, LLP holds 50,089 shares of TECH stock, worth $2.97 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

50,089

Holding current value

$2.97 Million

% of portfolio

0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$49.87 - $58.78 $2.5 Million - $2.94 Million	50,089 New	50,089 $2.79 Million
Q1 2025 May 15, 2025	SELL	$58.47 - $78.75 $37.8 Million - $50.9 Million	-646,071 Reduced 42.43%	876,622 $51.4 Million
Q4 2024 Feb 13, 2025	SELL	$66.37 - $78.17 $15.9 Million - $18.8 Million	-240,101 Reduced 13.62%	1,522,693 $110 Million
Q3 2024 Nov 14, 2024	SELL	$70.96 - $82.35 $15.7 Million - $18.2 Million	-220,943 Reduced 11.14%	1,762,794 $141 Million
Q2 2024 Aug 14, 2024	SELL	$62.12 - $84.15 $6.73 Million - $9.12 Million	-108,334 Reduced 5.18%	1,983,737 $142 Million

Q1 2024 May 15, 2024	SELL	$65.98 - $77.09 $13.2 Million - $15.4 Million	-199,865 Reduced 8.72%	2,092,071 $147 Million
Q4 2023 Feb 14, 2024	SELL	$52.83 - $78.22 $15.5 Million - $22.9 Million	-292,679 Reduced 11.32%	2,291,936 $177 Million
Q3 2023 Nov 14, 2023	BUY	$67.52 - $89.42 $81.9 Million - $109 Million	1,213,612 Added 88.52%	2,584,615 $176 Million
Q2 2023 Aug 14, 2023	BUY	$73.76 - $85.98 $96.4 Million - $112 Million	1,306,274 Added 2018.07%	1,371,003 $112 Million
Q1 2023 May 15, 2023	SELL	$71.62 - $86.62 $74.8 Million - $90.4 Million	-1,043,714 Reduced 94.16%	64,729 $4.8 Million
Q4 2022 Feb 14, 2023	BUY	$80.67 - $352.29 $42.5 Million - $186 Million	527,005 Added 90.64%	1,108,443 $91.9 Million
Q3 2022 Nov 14, 2022	BUY	$282.54 - $391.85 $37.7 Million - $52.3 Million	133,400 Added 29.77%	581,438 $165 Million
Q2 2022 Aug 15, 2022	BUY	$322.67 - $449.65 $54.5 Million - $76 Million	168,921 Added 60.52%	448,038 $155 Million
Q1 2022 May 16, 2022	SELL	$353.85 - $487.79 $107 Million - $147 Million	-301,718 Reduced 51.95%	279,117 $121 Million
Q4 2021 Feb 14, 2022	BUY	$456.15 - $525.06 $160 Million - $184 Million	350,215 Added 151.86%	580,835 $300 Million
Q3 2021 Nov 15, 2021	BUY	$444.87 - $538.88 $68 Million - $82.4 Million	152,847 Added 196.53%	230,620 $112 Million
Q2 2021 Aug 13, 2021	SELL	$387.35 - $450.26 $68 Million - $79.1 Million	-175,581 Reduced 69.3%	77,773 $35 Million
Q1 2021 May 17, 2021	BUY	$314.62 - $411.0 $79.2 Million - $103 Million	251,577 Added 14157.4%	253,354 $96.8 Million
Q4 2020 Feb 16, 2021	SELL	$246.9 - $321.87 $6.18 Million - $8.06 Million	-25,031 Reduced 93.37%	1,777 $564,000
Q3 2020 Nov 16, 2020	BUY	$232.22 - $282.96 $6.23 Million - $7.59 Million	26,808 New	26,808 $6.64 Million
Q2 2020 Aug 13, 2020	SELL	$185.43 - $279.56 $4.75 Million - $7.16 Million	-25,611 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$161.17 - $221.51 $1.41 Million - $1.93 Million	-8,729 Reduced 25.42%	25,611 $4.86 Million
Q4 2019 Feb 14, 2020	SELL	$189.68 - $222.09 $2.08 Million - $2.44 Million	-10,989 Reduced 24.24%	34,340 $7.54 Million
Q3 2019 Nov 14, 2019	BUY	$183.56 - $216.72 $8.32 Million - $9.82 Million	45,329 New	45,329 $8.87 Million
Q1 2019 May 14, 2019	SELL	$136.09 - $200.44 $55,932 - $82,380	-411 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$132.75 - $203.8 $2.88 Million - $4.42 Million	-21,678 Reduced 98.14%	411 $60,000
Q3 2018 Nov 14, 2018	BUY	$147.44 - $204.11 $3.26 Million - $4.51 Million	22,089 New	22,089 $4.51 Million

Others Institutions Holding TECH

# of Institutions

649

Shares Held

162M

Call Options Held

514K

Put Options Held

347K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.33B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account